Literature DB >> 29196030

Expert opinions on the acceptance of alternative methods in food safety evaluations: Formulating recommendations to increase acceptance of non-animal methods for kinetics.

Ans Punt1, Hans Bouwmeester2, Marie-Jeanne W A Schiffelers3, Ad A C M Peijnenburg4.   

Abstract

Inclusion of alternative methods that replace, reduce, or refine (3R) animal testing within regulatory safety evaluations of chemicals generally faces many hurdles. The goal of the current work is to i) collect responses from key stakeholders involved in food safety evaluations on what they consider the most relevant factors that influence the acceptance and use of 3R methods and to ii) use these responses to formulate activities needed to increase the acceptance and use of 3R methods, particularly for kinetics. The stakeholders were contacted by e-mail for their opinions, asking the respondents to write down three barriers and/or drivers and scoring these by distributing 5 points over the three factors. The main barriers that obtained the highest aggregated scores were i) uncertain predictability 3R methods/lack of validation, ii) insufficient guidance regulators/industry and iii) insufficient harmonization of legislation. The major driver identified was the possibility of 3R methods to provide more mechanistic information. Based on the results, recommendations are given to enhance the acceptance and application of 3R toxicokinetic methods in food safety evaluations. These include steering of regulatory data requirements as well as creating (funding) opportunities for development and validation of alternative methods for kinetics and development of guidances.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords:  Alternatives to animal testing; Drivers and barriers; Food toxicology; Multilevel perspective on technology transitions; QIVIVE; Regulatory acceptance

Mesh:

Year:  2017        PMID: 29196030     DOI: 10.1016/j.yrtph.2017.11.015

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  4 in total

1.  Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity.

Authors:  Aldert H Piersma; Nancy C Baker; George P Daston; Burkhard Flick; Michio Fujiwara; Thomas B Knudsen; Horst Spielmann; Noriyuki Suzuki; Katya Tsaioun; Hajime Kojima
Journal:  Curr Res Toxicol       Date:  2022-05-13

2.  Transcriptome comparisons of in vitro intestinal epithelia grown under static and microfluidic gut-on-chip conditions with in vivo human epithelia.

Authors:  Kornphimol Kulthong; Guido J E J Hooiveld; Loes Duivenvoorde; Ignacio Miro Estruch; Victor Marin; Meike van der Zande; Hans Bouwmeester
Journal:  Sci Rep       Date:  2021-02-05       Impact factor: 4.379

3.  Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro-in vivo extrapolation.

Authors:  Engi Abd El-Hady Algharably; Emma Di Consiglio; Emanuela Testai; Reinhold Kreutz; Ursula Gundert-Remy
Journal:  Arch Toxicol       Date:  2021-02-19       Impact factor: 5.153

4.  In Vitro-In Vivo Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons Learned.

Authors:  Engi Abdelhady Algharably; Emma Di Consiglio; Emanuela Testai; Francesca Pistollato; Hans Mielke; Ursula Gundert-Remy
Journal:  Front Toxicol       Date:  2022-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.